Join the 200th Anniversary Celebration

Original Article

Suppression of Alcohol-Induced Hypertension by Dexamethasone

Denis Randin, M.D., Peter Vollenweider, M.D., Luc Tappy, M.D., Eric Jéquier, M.D., Pascal Nicod, M.D., and Urs Scherrer, M.D.

N Engl J Med 1995; 332:1733-1738June 29, 1995

Abstract

Background

Alcohol consumption is associated with an increased incidence of hypertension and stroke, but the triggering mechanisms are unclear. In animals, alcohol causes activation of the sympathetic nervous system and also stimulates the release of corticotropin-releasing hormone (CRH), which has sympathoexcitatory effects when administered centrally.

Methods

To determine whether alcohol evokes sympathetic activation and whether such activation is attenuated by the inhibition of CRH release, we measured blood pressure, heart rate, and sympathetic-nerve action potentials (using intraneural microelectrodes) in nine normal subjects before and during an intravenous infusion of alcohol (0.5 g per kilogram of body weight over a period of 45 minutes) and for 75 minutes after the infusion. Each subject received two infusions, one after the administration of dexamethasone (2 mg per day) and one after the administration of a placebo for 48 hours.

Results

The infusion of alcohol alone evoked a marked (P<0.001) and progressive increase in the mean (±SD) rate of sympathetic discharge, from 16±3 bursts per minute at base line to 30±8 bursts per minute at the end of the two-hour period. This sympathetic activation was accompanied during the second hour by an increase in mean arterial pressure of 10±5 mm Hg (P<0.001). After the administration of dexamethasone, the alcohol infusion had no detectable sympathetic effect. The dexamethasone-induced suppression of sympathetic activation was associated with a decrease in mean arterial pressure of 7±6 mm Hg (P<0.001) during the alcohol infusion and with suppression of the pressor effect during the second hour.

Conclusions

Alcohol induces pressor effects by sympathetic activation that appear to be centrally mediated. It is possible that these alcohol-induced hemodynamic and sympathetic actions could participate in triggering cardiovascular events.

Media in This Article

Figure 1Representative Recordings of Sympathetic-Nerve Activity in a Normal Subject before and 120 Minutes after the Start of the Alcohol Infusion.
Figure 3Mean (±SE) Changes in Arterial Pressure in Five Normal Subjects in Response to an Alcohol Infusion during the Administration of Placebo (●), Dexamethasone (□), or Phentolamine ().
Article

Alcohol consumption is a risk factor for stroke and is associated with a higher-than-expected incidence of hypertension.1-6 The underlying mechanism relating heavy alcohol consumption to cardiovascular events is unclear.7,8 One potential candidate is the sympathetic nervous system. The results of plasma catecholamine measurements after the short-term ingestion of alcohol in humans are conflicting,5,7,8 but direct recordings of sympathetic-nerve activity suggest that short-term alcohol ingestion in humans and both short- and long-term administration of ethanol in rats stimulate sympathetic-nerve discharge.9-11 Moreover, in rats the alcohol-induced increases in blood pressure and sympathetic activity are centrally mediated.12

Alcohol stimulates the secretion of corticotropin-releasing hormone (CRH) in rats,13,14 an effect that could explain why regular alcohol consumption stimulates cortisol secretion.15 In rats, the intracerebroventricular administration of CRH increases blood pressure16 and stimulates sympathetic activity,17 and the inhibition of CRH release by dexamethasone attenuates stress-induced sympathetic activation.18 In humans dexamethasone, possibly by its inhibitory effect on CRH release, inhibits insulin-induced sympathetic activation.19

We attempted to determine whether the short-term intravenous administration of alcohol stimulates sympathetic-nerve activity and, if so, whether the administration of dexamethasone attenuates this sympathetic activation in normal humans. We therefore measured sympathetic-nerve activity and hemodynamic changes during two infusions of alcohol, one after the administration of dexamethasone and the other after the administration of placebo. To gain further insight into the relation between the sympathetic and vascular actions of alcohol, we tested the effects of an alpha-adrenergic–receptor blockade on the hemodynamic response to an alcohol infusion.

Methods

Subjects

We studied nine normal subjects (three women and six men; mean [±SD] weight, 67±10 kg; height, 175±8 cm; body-mass index, 21.3±1.7; and age, 27±5 years). (Body-mass index was calculated as the weight in kilograms divided by the square of the height in meters.) All the subjects were normotensive, were taking no medications, and had no evidence of metabolic or cardiovascular disease. Their customary alcohol consumption was less than 50 g per week. All the studies were performed in the morning after an overnight fast over a period of one to six weeks. The subjects were asked to abstain from alcohol, caffeine, and tobacco for at least 24 hours before each study. The experimental protocol was approved by the Institutional Review Board on Human Investigation, and all subjects provided written informed consent.

General Procedures

The subjects were studied in the supine position. Data on heart rate (monitored with an electrocardiograph), respiratory excursions (pneumobelt), blood pressure (Finapres blood-pressure monitor [Ohmeda, Englewood, Colo.]),20 blood flow in the calf (venous-occlusion plethysmography),20 and sympathetic-nerve activity in efferent nerves were recorded continuously on an electrostatic recorder and a tape recorder (R71, TEAC, Tokyo, Japan). Respiratory excursions were monitored to detect the inadvertent performance of a Valsalva maneuver or prolonged expiration, since these respiratory maneuvers can stimulate sympathetic outflow.20 Intravenous catheters were inserted in a right and a left antecubital vein, one for the alcohol infusion and the other for blood sampling.

Recordings of Sympathetic-Nerve Activity

Postganglionic sympathetic-nerve activity was recorded with unipolar tungsten microelectrodes inserted selectively into muscle–nerve fasciculi of the peroneal nerve posterior to the fibular head by the microneurographic technique of Vallbo et al.21 The neural signals were amplified 20,000 to 50,000 times, filtered (band width, 700 to 2000 Hz), rectified, and integrated (time constant, 0.1 second) to obtain a display of the mean voltage of sympathetic activity. A recording of sympathetic activity was considered acceptable when it revealed spontaneous, pulse-synchronous bursts of neural activity, with the largest bursts showing a minimal signal-to-noise ratio of 3:1. In each study, we documented that we were recording the sympathetic outflow to skeletal muscle by demonstrating that the neural activity did not respond to arousal stimuli (a loud noise) or a pinch of the skin but showed a characteristically biphasic response to the Valsalva maneuver.22

For analysis, printed filtered and mean-voltage neurograms were inspected visually to identify bursts of sympathetic-nerve discharge. The recordings were all analyzed by the same observer, who was unaware of whether the subject had received dexamethasone or placebo before the study. The intraobserver and interobserver coefficients of variation of the mean in identifying bursts were less than 6 percent and less than 9 percent, respectively.20 Nerve traffic was expressed both as the number of bursts per minute, an index of the frequency of the activity, and as the number of bursts per minute times the mean amplitude of the bursts, an index of integrated (total) activity. For quantitative analysis, the results were normalized by transcribing the nerve recordings from FM tape to hard copy in such a way that mean burst amplitudes were comparable in all subjects.

Measurement of Blood Flow in Muscle

While recording the sympathetic-nerve outflow to the calf muscles in one leg, we simultaneously measured blood flow in the calf of the contralateral leg by venous-occlusion plethysmography, using mercury-in-Silastic strain gauges.20 The calf was elevated 10 to 15 cm above the level of the right atrium to collapse the veins. The circulation to the foot was arrested by inflating a cuff around the ankle during each determination of blood flow; determinations were made at 15-second intervals over a 5-minute period.

Analytic Methods

Plasma alcohol concentrations were measured enzymatically (Alcool PAP, Biomérieux, Mercy l'Etoile, France). Plasma norepinephrine was measured by high-performance liquid chromatography,20 and plasma insulin and cortisol by radioimmunoassay (Gamma-BCT Cortisol IDS, Boldon, United Kingdom). All samples from the same subject were analyzed at the same time in each assay.

Experimental Protocols

Alcohol Infusion after the Administration of Dexamethasone and Placebo

All nine subjects received in randomized, double-blind sequence either dexamethasone (2 mg per day in four divided doses) or identical placebo pills for 48 hours before each of two alcohol infusions. The last dose of dexamethasone or placebo was administered on the morning of the test. After base-line measurements for 30 minutes, alcohol (ethanol, 0.5 g per kilogram of body weight) diluted in normal saline to make a 10 percent solution was infused over a 45-minute period. Sympathetic-nerve activity and hemodynamic measurements were recorded for 5 minutes of each 15-minute period during the 30-minute base-line period, the 45 minutes of the alcohol infusion, and the 75 minutes after the infusion. Immediately thereafter, in six subjects, we used baroreceptor deactivation evoked by the Valsalva maneuver19 and stimulation of cutaneous afferent nerves by a two-minute immersion of the hand in ice water19 (the cold pressor test) to examine the effects of dexamethasone on the responses to stimuli of sympathetic discharge other than alcohol. Blood samples were collected at base line and 15, 30, 45, 60, 90, and 120 minutes after the start of the alcohol infusion for analysis of plasma concentrations of alcohol and hormones.

Effects of Alpha-Adrenergic Blockade (Phentolamine Infusion) on Hemodynamic Responses to Alcohol Infusion

We assessed the effects of alpha-adrenergic blockade on hemodynamic responses to alcohol infusion. The purpose of this part of the study was to determine whether the dexamethasone-induced attenuation of the alcohol-induced pressor response was causally related to the attenuation of alcohol-induced sympathetic activation. Five of the nine subjects participated in this test. After base-line measurements for 30 minutes, phentolamine was administered as a primed infusion (70 μg per kilogram given over a 5-minute period) and then as a continuous infusion (7 μg per kilogram per minute) for 55 minutes, after which alcohol (at the dose used in the first part of the study) and phentolamine (7 μg per kilogram per minute) were infused together for 45 minutes. After the cessation of the alcohol infusion, phentolamine was infused for another 75 minutes at the same dose. Hemodynamic measurements were recorded for 5 minutes during each 15-minute period of the 30-minute base-line period and of the 3 hours of the phentolamine infusion.

The efficacy of the alpha-adrenergic blockade was then assessed by examining the pressor response and the vascular-resistance response in the calf evoked by immersing the subject's hand in ice water for two minutes. The mean (±SD) arterial pressure increased by 25±9 mm Hg and the vascular resistance in the calf increased by 17±11 units before the phentolamine infusion, but the mean arterial pressure increased by only 13±4 mm Hg and the vascular resistance decreased by 5±14 units during the infusion.

Effects of a Bolus Dose of Dexamethasone on Sympathetic Activity and Arterial Pressure

We also determined the effects of the administration of a bolus dose of dexamethasone alone (in the absence of alcohol) on sympathetic-nerve traffic and arterial pressure. Five other normal subjects (four women and one man; weight, 62±8 kg; height, 169±7 cm; body-mass index, 22.0±1.6; and age, 27±6 years) participated. After base-line measurements for 30 minutes, 2 mg of dexamethasone was administered intravenously as a bolus dose, followed by an infusion of saline at the same rate and for the same duration as the infusion of alcohol in the first part of the study. Nerve traffic and arterial pressure were measured for two hours after the dexamethasone administration.

Statistical Analysis

Mean arterial pressure was calculated as diastolic blood pressure plus one third of the pulse pressure. Vascular resistance in the calf was determined as the mean arterial pressure in millimeters of mercury divided by the blood flow in milliliters per minute per 100 milliliters of tissue; it was expressed in units.

The measurements of sympathetic-nerve activity, blood flow in the calf, blood pressure, and heart rate that were collected for 5 of every 15 minutes were averaged to a single value.

The statistical analysis was performed with an analysis of variance with repeated measures and paired two-tailed t-tests. Unless otherwise indicated, data are given as means ±SD. A P value of less than 0.05 was considered to indicate statistical significance.

Results

Responses to the Alcohol Infusion after Dexamethasone and Placebo

The base-line values for sympathetic-nerve discharge, plasma norepinephrine concentration, vascular resistance in the calf, and blood pressure were not altered by the administration of dexamethasone. Compliance with the administration of dexamethasone was documented by the presence of plasma cortisol concentrations markedly lower than those measured after the administration of placebo (2.1±2.7 vs. 12.3±5.4 μg per deciliter [57±74 vs. 339±149 nmol per liter], P<0.001). The increases in plasma alcohol concentrations were similar under both experimental conditions (Table 1Table 1Responses to Alcohol Infusions Given after the Administration of Placebo or Dexamethasone for 48 Hours in Normal Subjects.). Base-line plasma insulin concentrations were higher (P = 0.004) after dexamethasone than after placebo. During the alcohol infusion, the mean plasma insulin concentration increased slightly, albeit significantly (P = 0.01), both after placebo (from 6.6±2.9 to 8.2±2.4 μU per milliliter [40±17 to 49±14 pmol per liter] at 120 minutes) and after dexamethasone (from 11.2±4.1 to 13.5±6.6 μU per milliliter [67±25 to 81±40 pmol per liter]).

After the administration of placebo, the alcohol infusion evoked marked, roughly linear increases in sympathetic-nerve activity (Figure 1Figure 1Representative Recordings of Sympathetic-Nerve Activity in a Normal Subject before and 120 Minutes after the Start of the Alcohol Infusion. and Figure 2Figure 2Mean (±SE) Effects of an Infusion of Alcohol in Nine Normal Subjects after the Administration of Placebo (●) or Dexamethasone (□). and Table 1); at the end of the two-hour study period, the frequency of sympathetic-nerve bursts had increased by 97±54 percent and total activity by 127±84 percent (P<0.001). During the second hour, this progressive stimulation of sympathetic-nerve discharge was accompanied by an increase of 10±5 mm Hg (P<0.001) in mean arterial pressure (Figure 2 and Table 1). The alcohol-induced increases in sympathetic-nerve discharge in skeletal muscle were reflected by significant increases in plasma norepinephrine concentrations. In contrast, the infusion of alcohol after the administration of dexamethasone had no detectable effect on sympathetic-nerve discharge (or on plasma norepinephrine concentrations). The lack of sympathetic activation was associated with a decrease of 7±6 mm Hg (P<0.001) in mean arterial pressure during the infusion of alcohol and with the absence of a pressor effect during the second hour (Figure 1 and Figure 2 and Table 1).

In contrast to its effects on alcohol-induced sympathetic activation, dexamethasone did not alter sympathetic responses to the Valsalva maneuver or to immersion of the hand in ice water. The peak sympathetic responses during a Valsalva maneuver were 69±11 bursts per minute after placebo and 62±7 after dexamethasone. During immersion of the hand in ice water, the peak sympathetic responses were 37±7 and 43±4 bursts per minute, respectively.

Cardiovascular Responses to the Alcohol Infusion during Alpha-Adrenergic Blockade

During the infusions of alcohol and phentolamine, the blood-pressure response (Figure 3Figure 3Mean (±SE) Changes in Arterial Pressure in Five Normal Subjects in Response to an Alcohol Infusion during the Administration of Placebo (●), Dexamethasone (□), or Phentolamine ().) and vascular-resistance response in the calf (decreasing from 54±24 units at base line to 41±26 units at 120 minutes, P = 0.001) mimicked those observed during the alcohol infusion after dexamethasone. In contrast, the peak response of the heart rate was more pronounced after phentolamine than after dexamethasone (88±20 vs. 69±7 beats per minute, P = 0.04).

Cardiovascular and Sympathetic Responses to a Bolus Dose of Dexamethasone

Dexamethasone had no detectable effect on arterial pressure, heart rate, vascular resistance in the calf, or sympathetic-nerve discharge. The mean values at base line and two hours after dexamethasone administration were as follows: mean arterial pressure, 94±8 and 96±9 mm Hg; heart rate, 61±8 and 63±9 beats per minute; vascular resistance in the calf, 57±16 and 59±14 units; and sympathetic-burst frequency, 20±6 and 21±6 bursts per minute.

Discussion

We found that an infusion of alcohol roughly doubled the rate of sympathetic-nerve discharge and increased arterial pressure, and that these sympathoexcitatory and pressor effects were blocked by the administration of dexamethasone. These findings indicate that alcohol exerts a pressor effect in humans by causing sympathetic activation, an effect that is probably centrally mediated. The results of previous studies of the effects of alcohol on sympathetic activity were conflicting.5,7,8 Moreover, in the studies in which alcohol was administered orally, the relative sympathoexcitatory contributions of alcohol itself, alcohol-induced gastric irritation and distention, and stimulation of insulin release could not be distinguished.23 Intravenous infusion of alcohol combined with direct measurement of sympathetic-nerve discharge allowed us to eliminate these confounding issues. Our results indicate that alcohol increases postganglionic sympathetic-nerve discharge and are consistent with the preliminary findings made after the oral administration of alcohol.9

Our results provide some mechanistic insight into alcohol-induced sympathetic activation. In rats, alcohol stimulates CRH release13,14; both alcohol12 and CRH18 exert sympathoexcitatory and pressor effects when administered centrally; and dexamethasone, presumably by inhibiting CRH release, attenuates stress-induced sympathetic activation.18 In this study of humans, dexamethasone impaired the ability of alcohol to stimulate the discharge of sympathetic nerves. This response was not related to a nonspecific impairment of sympathetic responsiveness, since dexamethasone had no effect on either the base-line rate of sympathetic-nerve firing or responses to stimuli other than alcohol. Taken together, the results in animals and humans are consistent with the concept that sympathetic activation is related to a central neural action of alcohol, possibly involving CRH release.

The suppression of sympathetic activation markedly altered the cardiovascular responses to an infusion of alcohol. After the administration of placebo, alcohol increased sympathetic-nerve activity, did not affect vascular resistance in a limb, and increased the heart rate and mean arterial pressure. After the administration of dexamethasone, sympathetic activity did not increase, and alcohol caused vasodilation in the calf and a decrease in mean arterial pressure. These results are strengthened by the studies with phentolamine, which demonstrated the importance of sympathetic activation in mediating alcohol-induced pressor responses, and they have implications for the effects of alcohol on blood pressure in patients who either have autonomic dysfunction or are taking alpha-adrenergic–blocker drugs.

Increases in the heart rate during the administration of alcohol are thought to be mediated sympathetically because they are abolished by propranolol.24 In our study, increases in the heart rate after dexamethasone were similar to those after placebo, not greater, even though suppression of the pressor response would be expected to result in the removal of baroreflex restraint on heart-rate responses (as evidenced by the greater response in the heart rate during the infusion of alcohol in the phentolamine studies). Therefore, it appears that dexamethasone also attenuated alcohol-induced stimulation of sympathetic outflow to the heart.

Alcohol consumption is associated with an increased incidence of hypertension4-6 and stroke.1-3 Although many factors have been implicated in the pathogenesis of alcohol-induced cardiovascular complications,1,25 sympathetic activation could conceivably trigger acute events by promoting short-term increases in blood pressure and platelet aggregation.26,27 Whether sympathetic activation also contributes to long-term elevation of arterial pressure in persons who drink alcohol every day needs further investigation, but results from studies of rats suggest that this could be the case.11

Presented in part at the 47th Annual Fall Conference and Scientific Sessions of the Council for High Blood Pressure Research, San Francisco, September 28–October 1, 1993.

Supported by a grant (32-36280.92) from the Swiss National Science Foundation and by Nestec, Vevey, Switzerland; the International Olympic Committee; and the Max Cloëtta Foundation.

We are indebted to Drs. Laurent Vollenweider and Reza Owlya for assistance with some of these studies.

Source Information

From the Department of Internal Medicine B, Centre Hospitalier Universitaire Vaudois (D.R., P.N., U.S.); and the Institute of Physiology, University of Lausanne (P.V., L.T., E.J.) — both in Lausanne, Switzerland.

Address reprint requests to Dr. Scherrer at the Department of Internal Medicine B, BH 10.642, CHUV, CH-1011 Lausanne, Switzerland.

References

References

  1. 1

    Gill JS, Zezulka AV, Shipley MJ, Gill SK, Beevers DG. Stroke and alcohol consumption. N Engl J Med 1986;315:1041-1046
    Full Text | Web of Science | Medline

  2. 2

    Hillbom M, Kaste M. Ethanol intoxication: a risk factor for ischemic brain infarction. Stroke 1983;14:694-699
    CrossRef | Web of Science | Medline

  3. 3

    Donahue RP, Abbott RD, Reed DM, Yano K. Alcohol and hemorrhagic stroke: the Honolulu heart program. JAMA 1986;255:2311-2314
    CrossRef | Web of Science | Medline

  4. 4

    Klatsky AL, Friedman GD, Siegelaub AB, Gerard MJ. Alcohol consumption and blood pressure: Kaiser-Permanente Multiphasic Health examination data. N Engl J Med 1977;296:1194-1200
    Full Text | Web of Science | Medline

  5. 5

    MacMahon S. Alcohol consumption and hypertension. Hypertension 1987;9:111-121
    Web of Science | Medline

  6. 6

    Klag MJ, He J, Whelton PK, Chen J-Y, Quian M-C, He G-Q. Alcohol use and blood pressure in an unacculturated society. Hypertension 1993;22:365-370
    Web of Science | Medline

  7. 7

    Arkwright PD, Beilin LJ, Vandongen R, Rouse IA, Lalor C. The pressor effect of moderate alcohol consumption in man: a search for mechanisms. Circulation 1982;66:515-519
    CrossRef | Web of Science | Medline

  8. 8

    Howes LG, Reid JL. The effects of alcohol on local, neural and humoral cardiovascular regulation. Clin Sci 1986;71:9-15
    Web of Science | Medline

  9. 9

    Grassi GM, Somers VK, Renk WS, Abboud FM, Mark AL. Effects of alcohol intake on blood pressure and sympathetic nerve activity in normotensive humans: a preliminary report. J Hypertens Suppl 1989;7:S20-S21
    Medline

  10. 10

    Zhang X, Abdel-Rahman ARA, Wooles WR. A differential action for ethanol on baroreceptor reflex control of heart rate and sympathetic efferent discharge in rats. Proc Soc Exp Biol Med 1988;187:14-21
    Web of Science | Medline

  11. 11

    Russ R, Abdel-Rahman A-RA, Wooles WR. Role of the sympathetic nervous system in ethanol-induced hypertension in rats. Alcohol 1991;8:301-307
    CrossRef | Web of Science | Medline

  12. 12

    Zhang X, Abdel-Rahman AA, Wooles WR. Impairment of baroreceptor reflex control of heart rate but not sympathetic efferent discharge by central neuroadministration of ethanol. Hypertension 1989;14:282-292
    Web of Science | Medline

  13. 13

    Rivier C, Bruhn T, Vale W. Effect of ethanol on the hypothalamic-pituitary-adrenal axis in the rat: role of corticotropin-releasing factor (CRF). J Pharmacol Exp Ther 1984;229:127-131
    Web of Science | Medline

  14. 14

    Rivier C, Imaki T, Vale W. Prolonged exposure to alcohol: effect on CRF mRNA levels, and CRF- and stress-induced ACTH secretion in the rat. Brain Res 1990;520:1-5
    CrossRef | Web of Science | Medline

  15. 15

    Jenkins JS, Connolly J. Adrenocortical response to ethanol in man. BMJ 1968;2:804-805
    CrossRef | Web of Science | Medline

  16. 16

    Overton JM, Fisher LA. Central nervous system actions of corticotropin-releasing factor on cardiovascular function in the absence of locomotor activity. Regul Pept 1989;25:315-324
    CrossRef | Web of Science | Medline

  17. 17

    Kurosawa M, Sato A, Swenson RS, Takahashi Y. Sympatho-adrenal medullary functions in response to intracerebroventricularly injected corticotropin-releasing factor in anesthetized rats. Brain Res 1986;367:250-257
    CrossRef | Web of Science | Medline

  18. 18

    Brown MR, Fisher AL. Corticotropin-releasing factor: effects on the autonomic nervous system and visceral systems. Fed Proc 1985;44:243-248
    Medline

  19. 19

    Scherrer U, Vollenweider P, Randin D, Jequier E, Nicod P, Tappy L. Suppression of insulin-induced sympathetic activation and vasodilation by dexamethasone in humans. Circulation 1993;88:388-394
    Web of Science | Medline

  20. 20

    Vollenweider P, Tappy L, Randin D, et al. Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans. J Clin Invest 1993;92:147-154
    CrossRef | Web of Science | Medline

  21. 21

    Vallbo AB, Hagbarth KE, Torebjork HE, Wallin BG. Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves. Physiol Rev 1979;59:919-957
    Web of Science | Medline

  22. 22

    Scherrer U, Vissing SF, Morgan BJ, et al. Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N Engl J Med 1990;323:693-699
    Full Text | Web of Science | Medline

  23. 23

    Berne C, Fagius J, Niklasson F. Sympathetic response to oral carbohydrate administration: evidence from microelectrode nerve recordings. J Clin Invest 1989;84:1403-1409
    CrossRef | Web of Science | Medline

  24. 24

    Nakano J, Prancan AV. Effects of adrenergic blockade on cardiovascular responses to ethanol and acetaldehyde. Arch Int Pharmacodyn Ther 1972;196:259-268
    Web of Science | Medline

  25. 25

    Altura BM, Altura BT, Gebrewold A. Alcohol-induced spasms of cerebral blood vessels: relation to cerebrovascular accidents and sudden death. Science 1983;220:331-333
    CrossRef | Web of Science | Medline

  26. 26

    Clayton S, Cross MJ. The aggregation of blood platelets by catecholamines and by thrombin. J Physiol (Lond) 1963;169:82P-83P

  27. 27

    Sloan JA, Hooper M, Izzo JL Jr. Effects of circulating norepinephrine on platelets, leukocyte and red blood cell counts by alpha1-adrenergic stimulation. Am J Cardiol 1989;63:1140-1142
    CrossRef | Web of Science | Medline

Citing Articles (53)

Citing Articles

  1. 1

    Yohei Sagawa, Hideaki Kondo, Namiko Matsubuchi, Takaubu Takemura, Hironobu Kanayama, Yoshihiko Kaneko, Takashi Kanbayashi, Yasuo Hishikawa, Tetsuo Shimizu. (2011) Alcohol Has a Dose-Related Effect on Parasympathetic Nerve Activity During Sleep. Alcoholism: Clinical and Experimental Research 35:11, 2093-2100
    CrossRef

  2. 2

    Dagmara Hering, Wieslawa Kucharska, Tomas Kara, Virend K Somers, Krzysztof Narkiewicz. (2011) Potentiated sympathetic and hemodynamic responses to alcohol in hypertensive vs. normotensive individuals. Journal of Hypertension 29:3, 537-541
    CrossRef

  3. 3

    John C.M. Brust. 2011. Stroke and Substance Abuse. , 790-813.
    CrossRef

  4. 4

    Jerome L. Abramson, Cheryl Lewis, Nancy V. Murrah. (2010) Relationship of Self-Reported Alcohol Consumption to Ambulatory Blood Pressure in a Sample of Healthy Adults. American Journal of Hypertension 23:9, 994-999
    CrossRef

  5. 5

    Urs Scherrer, Emrush Rexhaj, Pierre-Yves Jayet, Yves Allemann, Claudio Sartori. (2010) New Insights in the Pathogenesis of High-Altitude Pulmonary Edema. Progress in Cardiovascular Diseases 52:6, 485-492
    CrossRef

  6. 6

    Urs Scherrer, Yves Allemann, Pierre-Yves Jayet, Emrush Rexhaj, Claudio Sartori. (2010) High Altitude, A Natural Research Laboratory for the Study of Cardiovascular Physiology and Pathophysiology. Progress in Cardiovascular Diseases 52:6, 451-455
    CrossRef

  7. 7

    Jürgen Rehm, Dolly Baliunas, Guilherme L. G. Borges, Kathryn Graham, Hyacinth Irving, Tara Kehoe, Charles D. Parry, Jayadeep Patra, Svetlana Popova, Vladimir Poznyak, Michael Roerecke, Robin Room, Andriy V. Samokhvalov, Benjamin Taylor. (2010) The relation between different dimensions of alcohol consumption and burden of disease: an overview. Addiction 105:5, 817-843
    CrossRef

  8. 8

    Yuhei Kawano. (2010) Physio-pathological effects of alcohol on the cardiovascular system: its role in hypertension and cardiovascular disease. Hypertension Research 33:3, 181-191
    CrossRef

  9. 9

    W-K Hsieh, H-H Lin, C-C Lai. (2009) Involvement of protein kinase C and Src tyrosine kinase in acute tolerance to ethanol inhibition of spinal NMDA-induced pressor responses in rats. British Journal of Pharmacology 158:3, 806-818
    CrossRef

  10. 10

    Sylvie Naveau, Juliette Thaury, Nadège Barri-Ova, Axel Balian, Barbara Dauvois, Micheline Njiké-Nakseu, Sophie Prévot, Hélène Agostini, Gabriel Perlemuter. (2009) Predictive Factors for Pure Steatosis in Alcoholic Patients. Alcoholism: Clinical and Experimental Research 33:6, 1104-1110
    CrossRef

  11. 11

    Scott H. Stewart, Gabor Oroszi, Patrick K. Randall, Raymond F. Anton. (2009) COMT Genotype Influences the Effect of Alcohol on Blood Pressure: Results From the COMBINE Study. American Journal of Hypertension 22:1, 87-91
    CrossRef

  12. 12

    Giorgio SOARDO, Debora DONNINI, Massimo MORETTI, Carla MILOCCO, Cristiana CATENA, Leonardo A. SECHI. (2008) Effects of Antihypertensive Drugs on Alcohol-Induced Functional Responses of Cultured Human Endothelial Cells. Hypertension Research 31:2, 345-351
    CrossRef

  13. 13

    M. H. Criqui. 2007. Do Known Cardiovascular Risk Factors Mediate the Effect of Alcohol on Cardiovascular Disease?. , 159-172.
    CrossRef

  14. 14

    John C.M. Brust. 2007. Éthanol. , 385-516.
    CrossRef

  15. 15

    André Avelino Steffens, Leila Beltrami Moreira, Sandra Costa Fuchs, Mário Wiehe, Miguel Gus, Flávio Danni Fuchs. (2006) Incidence of hypertension by alcohol consumption: is it modified by race?. Journal of Hypertension 24:8, 1489-1492
    CrossRef

  16. 16

    Giorgio Soardo, Debora Donnini, Rosanna Varutti, Carla Milocco, Lorenza Basan, Walter Esposito, Daniele Casaccio, Miriam Isola, Franca Soldano, Leonardo A Sechi. (2006) Effects of alcohol withdrawal on blood pressure in hypertensive heavy drinkers. Journal of Hypertension 24:8, 1493-1498
    CrossRef

  17. 17

    Silke Heindl, Kerstin Vahlkamp, Gunther Weitz, Horst Lorenz Fehm, Christoph Dodt. (2006) Differential effects of hydrocortisone on sympathetic and hemodynamic responses to sympathoexcitatory manoeuvres in men. Steroids 71:3, 206-213
    CrossRef

  18. 18

    Paulo Fernando Dotto Bau, Claiton H.D. Bau, Alexandre A. Naujorks, Guido A. Rosito. (2005) Early and late effects of alcohol ingestion on blood pressure and endothelial function. Alcohol 37:1, 53-58
    CrossRef

  19. 19

    Michael Huntgeburth, Henrik ten Freyhaus, Stephan Rosenkranz. (2005) Alcohol consumption and hypertension. Current Hypertension Reports 7:3, 180-185
    CrossRef

  20. 20

    P Scott Barrilleaux, James N. Martin, Chad K. Klauser, Laura Bufkin, Warren L. May. (2005) Postpartum Intravenous Dexamethasone for Severely Preeclamptic Patients Without Hemolysis, Elevated Liver Enzymes, Low Platelets (HELLP) Syndrome: A Randomized Trial. Obstetrics & Gynecology 105:4, 843-848
    CrossRef

  21. 21

    Rachel P Wildman, Dongfeng Gu, Paul Muntner, Guangyong Huang, Jichun Chen, Xianfeng Duan, Jiang He. (2005) Alcohol intake and hypertension subtypes in Chinese men. Journal of Hypertension 23:4, 737-743
    CrossRef

  22. 22

    G. Seematter, C. Binnert, L. Tappy. (2005) Stress and Metabolism. Metabolic Syndrome and Related Disorders 3:1, 8-13
    CrossRef

  23. 23

    Ramon Estruch, Antonio Coca, Jos?? L Rodicio. (2005) High blood pressure, alcohol and cardiovascular risk. Journal of Hypertension 23:1, 226-229
    CrossRef

  24. 24

    John C.M. Brust. 2004. Stroke and Substance Abuse. , 725-745.
    CrossRef

  25. 25

    Osamu TOCHIKUBO, Kiyoko NISHIJIMA. (2004) Sodium Intake and Cardiac Sympatho-Vagal Balance in Young Men with High Blood Pressure. Hypertension Research 27:6, 393-398
    CrossRef

  26. 26

    Ram??n Estruch, Emilio Sacanella, Alejandro De la Sierra, Mar??a Teresa Aguilera, Em??lia Ant??nez, Jos?? M. Nicol??s, Joaqu??n Fern??ndez-Sol??, Antonio Coca, ??lvaro Urbano-M??rquez. (2003) Effects of Alcohol Withdrawal on 24 Hour Ambulatory Blood Pressure Among Alcohol-Dependent Patients. Alcoholism: Clinical & Experimental Research 27:12, 2002-2008
    CrossRef

  27. 27

    William H. Frishman, Alexander Del Vecchio, Shirin Sanal, Anjum Ismail. (2003) Cardiovascular Manifestations of Substance Abuse. Heart Disease 5:4, 253-271
    CrossRef

  28. 28

    Urs Scherrer, Guido Grassi. (2003) Reduced sympathetic cardiovascular drive in young adults with low birth weight. Journal of Hypertension 21:5, 867-868
    CrossRef

  29. 29

    L. Beilin, I. Puddey. (2003) Journal of Cardiovascular Risk 10:1, 1-3
    CrossRef

  30. 30

    Joel Handler. (2003) Drug-Induced Hypertension. The Journal of Clinical Hypertension 5:1, 83-85
    CrossRef

  31. 31

    A Klatsky. 2002. Wine, alcohol and cardiovascular diseases. , 108-139.
    CrossRef

  32. 32

    Cristiana Gennaro, Pier Paolo Vescovi, Angela Luciana Barilli, Cristina Giuffredi, Roberto Delsignore, Alberto Montanari. (2002) Sodium Sensitivity as a Main Determinant of Blood Pressure Changes during Early Withdrawal in Heavy Alcoholics. Alcoholism: Clinical and Experimental Research 26:12, 1810-1815
    CrossRef

  33. 33

    Christopher B. McFadden, Raymond R. Townsend. (2002) Alcohol's (other) Dark Side. The Journal of Clinical Hypertension 4:5, 362-362
    CrossRef

  34. 34

    G. Seematter, P. Battilana, L. Tappy. (2002) Effects of dexamethasone on the metabolic responses to mental stress in humans. Clinical Physiology and Functional Imaging 22:2, 139-144
    CrossRef

  35. 35

    Cristiana Gennaro, Pier Paolo Vescovi, Angela Luciana Barilli, Cristina Giuffredi, Roberto Delsignore, Alberto Montanari. (2002) Sodium Sensitivity as a Main Determinant of Blood Pressure Changes during Early Withdrawal in Heavy Alcoholics. Alcoholism: Clinical and Experimental Research 26:12, 1810
    CrossRef

  36. 36

    William C. Cushman. (2001) Alcohol Consumption and Hypertension. The Journal of Clinical Hypertension 3:3, 166-170
    CrossRef

  37. 37

    Maria-Teresa Olivari. (2000) Behavioral and environmental factors contributing to the development and progression of congestive heart failure11The author wishes to thank Tim Furlong for excellent secretarial assistance in the preparation of this manuscript.. The Journal of Heart and Lung Transplantation 19:8, S12-S20
    CrossRef

  38. 38

    V.M.M Ferreira, R.N Takahashi, G.S Morato. (2000) Dexamethasone Reverses the Ethanol-Induced Anxiolytic Effect in Rats. Pharmacology Biochemistry and Behavior 66:3, 585-590
    CrossRef

  39. 39

    Lynn M. Baxendale-Cox. (2000) An Overview of Essential Hypertension in Americans as a Multifactorial Phenomenon: Interaction of Biologic and Environmental Factors. Progress in Cardiovascular Nursing 15:2, 43-49
    CrossRef

  40. 40

    Wendy L. Adams. (1999) ALCOHOL AND THE HEALTH OF AGING MEN. Medical Clinics of North America 83:5, 1195-1211
    CrossRef

  41. 41

    Ronni Wolf, Binnur Tüzün, Yalcin Tüzün. (1999) Alcohol ingestion and the cutaneous vasculature11The opinions expressed herein are solely those of the writers and do not necessarily reflect the opinions of the institutions with which the writers are associated.. Clinics in Dermatology 17:4, 395-403
    CrossRef

  42. 42

    HEINZ RUPP. (1999) Excess Catecholamine Syndrome: Pathophysiology and Therapya. Annals of the New York Academy of Sciences 881:1 IMIDAZOLINE R, 430-444
    CrossRef

  43. 43

    P.Antonio Tataranni, Giovanni Cizza, Soren Snitker, Frank Gucciardo, Angela Lotsikas, George P. Chrousos, Eric Ravussin. (1999) Hypothalamic-pituitary-adrenal axis and sympathetic nervous system activities in Pima Indians and Caucasians. Metabolism 48:3, 395-399
    CrossRef

  44. 44

    Tito Livraghi, Viviano Benedini, Sergio Lazzaroni, Franca Meloni, Guido Torzilli, Claudio Vettori. (1998) Long term results of single session percutaneous ethanol injection in patients with large hepatocellular carcinoma. Cancer 83:1, 48-57
    CrossRef

  45. 45

    Mattia Lepori, Claudio Sartori, Lionel Trueb, Reza Owlya, Pascal Nicod, Urs Scherrer. (1998) Haemodynamic and sympathetic effects of inhibition of nitric oxide synthase by systemic infusion of NG-monomethyl-L-arginine into humans are dose dependent. Journal of Hypertension 16:4, 519-523
    CrossRef

  46. 46

    Christoph Dodt, Gunnar Wallin, Horst L. Fehm, Mikael Elam. (1998) The stress hormone adrenocorticotropin enhances sympathetic outflow to the muscle vascular bed in humans. Journal of Hypertension 16:2, 195-201
    CrossRef

  47. 47

    Kaspar Berneis, Ronald Ninnis, Ulrich Keller. (1997) Ethanol exerts acute protein-sparing effects during postabsorptive but not during anabolic conditions in man. Metabolism 46:7, 750-755
    CrossRef

  48. 48

    IAN B. PUDDEY, LAWRENCE J. BEILIN, VALENTINA RAKIC. (1997) Alcohol, hypertension and the cardiovascular system: a critical appraisal. Addiction Biology 2:2, 159-170
    CrossRef

  49. 49

    Peter Weidmann, Adrian U. Teuscher, Lorenz Böhlen. (1997) Treatment of elevated blood pressure in diabetic patients. Journal of Diabetes and its Complications 11:2, 92-99
    CrossRef

  50. 50

    Harvey E. Finkel. (1996) Wine and health: a review and perspective. Journal of Wine Research 7:3, 157-196
    CrossRef

  51. 51

    Urs Scherrer, Reza Owlya, Mattic Leport. (1996) Body fat and sympathetic nerve activity. Cardiovascular Drugs and Therapy 10:S1, 215-222
    CrossRef

  52. 52

    A. L. Klatsky, M.D. (1996) ALCOHOL, CORONARY DISEASE, AND HYPERTENSION. Annual Review of Medicine 47:1, 149-160
    CrossRef

  53. 53

    Victor, Ronald G., Hansen, Jim, . (1995) Alcohol and Blood Pressure — A Drink a Day . . .. New England Journal of Medicine 332:26, 1782-1783
    Full Text